This inventor holds 2 USPTO granted patents. Top assignee: University of Delaware. Active years: 2010-2011.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Newark, DE (US) (2010)
- Bear, DE (US) (2011)
Company Filing History:
Years Active: 2010-2011
Title: Innovations by Jeffrey B. Safran
Introduction
Jeffrey B. Safran is an accomplished inventor based in Bear, Delaware. He has made significant contributions to the field of bioactive peptides and their applications in cell adhesion. With a total of 2 patents, his work focuses on developing innovative solutions for enhancing cell growth and differentiation.
Latest Patents
Safran's latest patents include groundbreaking inventions related to bioactive peptides for cell adhesion. One patent describes implantable devices designed for adhering eukaryotic cells and providing a substrate for eukaryotic cell growth and/or differentiation in vitro. These devices feature a scaffold coated with a protein that includes an adhesive polypeptide with at least 90% sequence identity to a specific peptide sequence within domain IV of perlecan. This technology enables the adhesion of various cell types, including epithelial cells, epithelial stem cells, mesenchymal stem cells, and osteoblasts. Another patent focuses on a polypeptide derived from domain IV of the extracellular matrix protein perlecan, which can selectively adhere cells. This invention encompasses nucleic acids encoding the polypeptide, vectors containing these nucleic acids, and methods for adhering cells to a scaffold using the innovative polypeptide.
Career Highlights
Jeffrey B. Safran is affiliated with the University of Delaware, where he continues to advance research in the field of bioactive materials. His work has garnered attention for its potential applications in regenerative medicine and tissue engineering.
Collaborations
Safran collaborates with notable colleagues, including Mary C. Farach-Carson and Daniel D. Carson, who contribute to his research endeavors and enhance the impact of his inventions.
Conclusion
Jeffrey B. Safran's innovative work in bioactive peptides and cell adhesion represents a significant advancement in the field of biomedical engineering. His contributions have the potential to revolutionize approaches to cell growth and tissue regeneration.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile